Evidence map›Paper›PMID 42648756›Full record

ArticleBMJ global health2026

Impact of Russian invasion on radiation therapy capacity in Ukraine: a national survey study.

Zoia Shepil, Vladyslav Buryk, Ruslan Zelinskyi, Larysa Stadnyk, Yuliia Lozko, Serhii Brovchuk, Lesia Mytsak, Yulia Romalis, Rohini Bhatia, Natalka Suchowerska and 4 more

Abstract read
In one paragraph

Article in BMJ global health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Zoia ShepilRadiation Oncology, National Institute "O.O. Shalimov National Scientific Center of Surgery and Transplantology", Kyiv, Ukraine.ORCID 0009-0004-5584-3918
Vladyslav BurykRadiation Oncology, Stereotactic Radiosurgery Center, Sigulda, Latvia.
Ruslan ZelinskyiHelp Ukraine Group, San Carlos, California, USA.ORCID 0009-0007-8130-1903
Larysa StadnykGrigoriev Institute for Medical Radiology and Oncology of the National Academy of Medical Sciences of Ukraine, Kharkiv, Ukraine.
Yuliia LozkoHelp Ukraine Group, San Carlos, California, USA.
Serhii BrovchukRadiation Oncology, National Institute "O.O. Shalimov National Scientific Center of Surgery and Transplantology", Kyiv, Ukraine.
Lesia MytsakRadiation Oncology, Precarpathian Clinical Oncology Center, Ivano Frankivsk, Ukraine.
Yulia RomalisRadiation Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
Rohini BhatiaEmory University Winship Cancer Institute, Atlanta, Georgia, USA.
Natalka SuchowerskaHelp Ukraine Group, San Carlos, California, USA.
Viktor IakovenkoHelp Ukraine Group, San Carlos, California, USA.
Darya KizubBreast Medical Oncology, MD Anderson Cancer Center, Houston, Texas, USA.
Nelya MelnitchoukGastrointestinal and General Surgery, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Nataliya KovalchukHelp Ukraine Group, San Carlos, California, USA natkoval@stanford.edu.ORCID 0000-0003-2619-7262

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThis study evaluated the operational status of Ukrainian radiotherapy (RT) centres to characterise wartime capacity following the Russian invasion and to identify priorities for improving RT delivery and resilience.

methodsThis cross-sectional study integrated two data sources: (1) a 38-item survey conducted by Help Ukraine Group (HUG) in August 2025 across all Ukrainian RT departments, assessing patient volumes, waiting times, equipment status, cobalt-60 (Co-60) source replacement, staffing, training needs and operational challenges; and (2) International Atomic Energy Agency DIRAC datasets collected by the Grigoriev Institute (2021-2025), tracking equipment, staffing and patient volumes. Descriptive and comparative analyses were performed.

resultsIn December 2021, before the full-scale invasion, Ukraine operated 41 RT departments with 82 megavoltage (MV) machines (38 linear accelerators, 44 Co-60 units), 53 orthovoltage units and 36 brachytherapy afterloaders. During the first 3 months of war, four centres were occupied, most departments experienced service disruptions averaging 26 days and patient volume declined by 27.5%. Volumes recovered to baseline in 2023 and increased by 8.9% in 2024 and 9.3% in 2025 relative to 2021.In December 2025, Ukraine operated 42 RT departments with 96 MV machines (68 linear accelerators, 28 Co-60 units), 38 orthovoltage units and 34 afterloaders. However, 56% of departments still relied on Co-60 and 94.1% reported future source replacement would be unfeasible because sources were historically procured from Russia. Consequently, 78.6% of Co-60 users planned the transition to linear accelerators. Workforce shortages remain critical, with reported deficits of 41.4% for medical physicists, 33.6% for RTTs and 21.1% for radiation oncologists. Average waiting times increased from 6.4 days in 2021 to 10.3 days in 2025.

conclusionDespite ongoing war, Ukraine is actively modernising RT services, with a rapid transition from Co-60 to linear accelerators. Workforce development and targeted training are now urgently needed to convert equipment investment into sustainable clinical capacity.

Indexed as

RadiotherapyCross-Sectional StudiesHumansRussiaSurveys and QuestionnairesUkraineCancerGlobal HealthViolence

Identifiers

PMID42648756
PMCPMC13536102

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.